Validated using a knockout cell line
Recombinant
RabMAb

Anti-Dnmt1 antibody [EPR3522] (ab92314)

Publishing research using ab92314? Please let us know so that we can cite the reference in this datasheet.

ab92314 has been referenced in 5 publications.

  • Molokie R  et al. Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study. PLoS Med 14:e1002382 (2017). PubMed: 28880867
  • Heuslein JL  et al. DNA Methyltransferase 1-Dependent DNA Hypermethylation Constrains Arteriogenesis by Augmenting Shear Stress Set Point. J Am Heart Assoc 6:N/A (2017). PubMed: 29191807
  • Goel S  et al. CDK4/6 inhibition triggers anti-tumour immunity. Nature 548:471-475 (2017). WB ; Mouse . PubMed: 28813415
  • Trejbalová K  et al. Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals. Clin Epigenetics 8:19 (2016). WB . PubMed: 26900410
  • Clements EG  et al. DNMT1 modulates gene expression without its catalytic activity partially through its interactions with histone-modifying enzymes. Nucleic Acids Res 40:4334-46 (2012). WB . PubMed: 22278882

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up